GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kontour (Xian) Medical Technology Co Ltd (SHSE:688314) » Definitions » Research & Development

Kontour (Xian) Medical Technology Co (SHSE:688314) Research & Development : ¥20.3 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Kontour (Xian) Medical Technology Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Kontour (Xian) Medical Technology Co's Research & Development for the three months ended in Sep. 2024 was ¥6.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ¥20.3 Mil.


Kontour (Xian) Medical Technology Co Research & Development Historical Data

The historical data trend for Kontour (Xian) Medical Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kontour (Xian) Medical Technology Co Research & Development Chart

Kontour (Xian) Medical Technology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 10.56 16.90 16.81 18.30 17.64

Kontour (Xian) Medical Technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.46 3.90 4.66 5.42 6.33

Kontour (Xian) Medical Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥20.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kontour (Xian) Medical Technology Co  (SHSE:688314) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Kontour (Xian) Medical Technology Co Research & Development Related Terms

Thank you for viewing the detailed overview of Kontour (Xian) Medical Technology Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Kontour (Xian) Medical Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Qinling Avenue West, Caotang Technology Industry Base, High-tech Zone, Shaanxi Province, Xi'an, CHN, 710304
Kontour (Xian) Medical Technology Co Ltd is engaged in the research and development, production, and sales of three types of implanted medical device products. It focuses on neurosurgery, cardiovascular surgery, craniofacial surgery, stomatology, and other professional fields.
Executives
Zhu Hai Long Directors, senior managers
Hu Li Ren Director
Wu Dong Director

Kontour (Xian) Medical Technology Co Headlines

No Headlines